Back to Search
Start Over
Epidemiology and 3‐year outcomes of combined oral contraceptive–associated distal deep vein thrombosis
- Source :
- Research and Practice in Thrombosis and Haemostasis, Research and Practice in Thrombosis and Haemostasis, 2020, 4 (7), pp.1216-1223. ⟨10.1002/rth2.12409⟩, Research and Practice in Thrombosis and Haemostasis, Wiley, 2020, 4 (7), pp.1216-1223. ⟨10.1002/rth2.12409⟩, Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 7, Pp 1216-1223 (2020)
- Publication Year :
- 2020
- Publisher :
- HAL CCSD, 2020.
-
Abstract
- International audience; Background: Distal deep vein thrombosis (infrapopliteal DVT without proximal DVT or pulmonary embolism [PE]) generally shares the same triggering risks factors as proximal DVT. In women of childbearing age, a frequent triggering risk factor is the use of combined oral contraceptive (COC) pills. However, data on the epidemiology and long-term outcomes of COC-associated distal DVT are lacking.Objectives: To assess the epidemiology and long-term outcomes of COC-associated distal DVT.Methods: Using data from the OPTIMEV (Optimisation de l'Interrogatoire dans l'évaluation du risque thrombo-Embolique Veineux [Optimization of Interrogation in the Assessment of Thromboembolic Venous Risk]) multicenter cohort study of patients with objectively confirmed venous thromboembolism (VTE) enrolled between 2004 and 2006, we assessed in nonpregnant or postpartum women aged ≤ 50 years without cancer or history of VTE (i) proportion of COC-associated distal DVTs among women with distal DVTs and among women with COC-associated VTEs (distal DVT, proximal DVT, or PE) and (ii) 3-year incidence of death, bleeding, and VTE recurrence.Results: COC-associated distal DVTs (n = 54) represented 43.9% of all distal DVTs and 51.9% of COC-associated VTEs. All but one woman with a COC-associated distal DVT received therapeutic anticoagulation for a median of 3 months. At 3-year follow-up, all women with COC-associated distal DVTs were alive, and none had bled during anticoagulant treatment or had experienced a DVT or PE recurrence after stopping anticoagulants. Similar results were found in patients with COC-associated proximal DVT and PE: The VTE recurrence rate was 1.7% per patient-year (PY) and 0% PY, respectively, and there were no deaths or major bleeds in either group.Conclusions: Distal DVT was the most frequent clinical presentation of COC-associated VTE and had similarly favorable long-term outcomes as other COC-associated VTE.
- Subjects :
- medicine.medical_specialty
Deep vein
030204 cardiovascular system & hematology
deep vein thrombosis
03 medical and health sciences
0302 clinical medicine
Epidemiology
medicine
risk factors
Diseases of the blood and blood-forming organs
030212 general & internal medicine
cardiovascular diseases
Risk factor
business.industry
Incidence (epidemiology)
Hematology
medicine.disease
Original Articles ‐ Thrombosis
Thrombosis
3. Good health
Surgery
Pulmonary embolism
Venous thrombosis
medicine.anatomical_structure
combined oral contraceptives
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
Original Article
epidemiology
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
venous thrombosis
RC633-647.5
business
Cohort study
estrogens
Subjects
Details
- Language :
- English
- ISSN :
- 24750379
- Database :
- OpenAIRE
- Journal :
- Research and Practice in Thrombosis and Haemostasis, Research and Practice in Thrombosis and Haemostasis, 2020, 4 (7), pp.1216-1223. ⟨10.1002/rth2.12409⟩, Research and Practice in Thrombosis and Haemostasis, Wiley, 2020, 4 (7), pp.1216-1223. ⟨10.1002/rth2.12409⟩, Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 7, Pp 1216-1223 (2020)
- Accession number :
- edsair.doi.dedup.....95d7f0261911b2cfdb220172840d658f
- Full Text :
- https://doi.org/10.1002/rth2.12409⟩